Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...
U.S. 3 Year Treasury Note-0.039 4.184% U.S. 5 Year Treasury Note-0.078 4.257% U.S. 7 Year Treasury Note-0.096 4.384% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results